TrueBlue (TBI) Tops Q1 EPS by 9c, Beat on Revenue; Offers Q2 Guidance

TrueBlue (NYSE: TBI) reported Q1 EPS of $0.21, $0.09 better than the analyst estimate of $0.12. Revenue for the quarter came in at $611.3 million versus the consensus estimate of $559.94 million.

GUIDANCE:

TrueBlue sees Q2 2017 EPS of $0.38-$0.43, versus the consensus of $0.43. TrueBlue sees Q2 2017 revenue of $600-615 million, versus the consensus of $611.21 million.

For earnings history and earnings-related data on TrueBlue (TBI) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Stardust Power (SDST) Tops Q2 EPS by 1c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18